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Protocol
AbstrACt
Introduction The recent global expansion of routine 
adolescent vaccination programmes has the potential to 
protect young people against the acquisition of infectious 
disease and improve their health. Although in many 
countries the legal framework supports young people 
to provide consent for medical interventions if they are 
considered competent, written parental consent can 
act as a barrier to uptake as it is frequently a condition 
of adolescent vaccination programmes. The aim of this 
systematic review protocol is to document the methods 
which will be used to identify, appraise and synthesise the 
available qualitative and quantitative evidence to address: 
(1) whether implementation of adolescent self-consent 
procedures can increase vaccination uptake and (2) the 
barriers and facilitators to implementation of adolescent 
self-consent procedures.
Methods and analysis Comprehensive search strategy 
of all relevant electronic databases for both qualitative 
and quantitative studies using predefined inclusion and 
exclusion criteria. At least two authors will independently 
review titles and abstracts, extract data and assess the 
methodological quality of eligible primary studies, resolving 
disagreements by consensus. Quantitative studies will be 
reported narratively and where possible pooled in a meta-
analysis using a random-effects model. The findings of 
qualitative primary studies will be extracted, interpreted 
and synthesised to identify overarching themes as well as 
similarities and differences within those themes.
Ethics and dissemination As this systematic review 
involves analysis of secondary data, the study does not 
require ethical approvals. We will use our findings to 
assess whether the evidence supports the hypothesis 
that self-consent procedures can increase coverage of 
adolescent vaccination programmes. We will identify 
barriers and facilitators to the implementation of 
adolescent self-consent for vaccination and make 
recommendations for policy makers and practitioners 
in relation to consent procedures within vaccination 
programmes for young people.
PrOsPErO registration number CRD42017084509.
IntrOduCtIOn 
In recent years, the number of routine vacci-
nations recommended during adolescence 
have increased and include vaccines that 
protect against tetanus, diphtheria, menin-
gitis and human papillomavirus (HPV) 
acquisition.1 2 Provided sufficient coverage 
is achieved, the expansion of adolescent 
vaccination programmes may improve 
young people’s health by protecting them 
from potentially life-threatening infectious 
diseases.
The introduction of new adolescent vacci-
nation programmes is relevant to the debate 
about young people’s capacity to provide 
consent to receive medical treatment. The 
United Nations Convention on the Rights 
of the Child recognises the right for all chil-
dren and young people to participate in deci-
sion-making processes which involve them.3 
However, the WHO has acknowledged diffi-
culties over consent for vaccination of adoles-
cents because of their age and describes 
current practice through which countries are 
encouraged to adopt procedures that ensure 
parents have been informed and agreed to 
the vaccination.4
In most countries, the legal framework 
for consent requires parental or guardian 
permission for young people aged below 
18 years.4 However, the age of consent for 
medical interventions, such as vaccination 
programmes, is lower in some countries. In 
the UK, Canada and Sweden, young women 
are legally able to override parental deci-
sions if they are considered mature enough 
to make and understand the consequences 
of, the decision to vaccinate. In Australia 
strengths and limitations of this study
 ► The mixed methods systematic review will answer 
complementary research questions about self-con-
sent for adolescent vaccination programmes.
 ► Robust systematic review methodology will be used 
to identify, appraise and synthesise the relevant 
qualitative and quantitative literature.
 ► Lack of primary studies and heterogeneity of eligi-
ble studies in terms of study design, population and 
reporting may limit our ability to infer conclusions in 
relation to the research questions.
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and theUSA, there are geographic variations of the age 
(12–17 years) that a young person can consent to be 
vaccinated. Despite young people being supported by 
the law to provide consent themselves, written parental 
consent is usually sought. In relation to the HPV vacci-
nation programme, this has been shown to act as an 
important barrier preventing young women (usually aged 
12–13 years) receiving the HPV vaccine, with implications 
for vaccination programme coverage.5 6 Furthermore, it 
is a barrier with potential to reinforce health inequalities 
since lack of written parental consent may also be related 
to lower socioeconomic status and some ethnic groups.5 7
To examine the issue of self-consent for the HPV 
vaccine in more detail, a mixed-methods study has been 
funded by the National Institute for Health Research 
(NIHR) Research for Patient Benefit Programme (RfPB) 
in England. The study is examining the practicality, 
acceptability and impact of implementing new self-con-
sent procedures for the schools-based HPV vaccination 
in two local authorities in the south-west of England.8 
There are three elements to the study: statistical anal-
yses of routine data to assess the impact of self-consent 
on overall uptake levels and in relation to socioeconomic 
status, ethnicity and type of school; a process evaluation 
to examine the context, implementation and response 
to the new consent procedures and a systematic review 
of the evidence relating to self-consent for adolescent 
vaccines. The current protocol focuses on the systematic 
review which will run alongside, and inform, the other 
elements of the study.
An initial scoping search suggested a paucity of peer-re-
viewed evidence in relation to self-consent procedures 
for HPV vaccination programmes. Since issues relating 
to self-consent for the HPV vaccination are likely to be 
relevant for other vaccinations delivered during adoles-
cence, we widened the scope of the systematic review to 
identify and collate the evidence across all adolescent 
vaccination programmes. We chose to restrict to vaccina-
tion programmes, rather than include studies related to 
healthcare in general, to ensure the findings were relevant 
to the programme of research described above. There-
fore, the aim of this mixed-methods systematic review is 
to identify, appraise and synthesise the available qualita-
tive and quantitative literature to gain understanding as 
to: (1) whether implementation of adolescent self-con-
sent procedures can increase vaccination uptake and (2) 
the related barriers and facilitators to implementation of 
adolescent self-consent procedures.
MEthOds And AnAlysIs
We are using mixed methods methodology within this 
systematic review to answer complementary research 
questions within one study. In addition to answering 
questions of the effectiveness of self-consent interven-
tions at increasing uptake of adolescent vaccination 
programmes, the systematic review will also synthesise 
qualitative research comprising the views of young people 
and relevant stakeholders to gain understanding of how 
self-consent procedures can be implemented effectively 
to increase uptake.9 The findings from the qualitative and 
quantitative studies will be integrated to produce recom-
mendations for future policy and practice.9
This review protocol was prepared using the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) Protocol guidelines10 (online supplemen-
tary file 1) and has been registered with the International 
Prospective Register of Systematic Reviews (PROSPERO) 
(Registration number: CRD42017084509).
search strategy
A comprehensive search strategy has been developed to 
capture all literature relevant to adolescent self-consent 
procedures for vaccination programmes by a reviewer 
(HF) experienced in undertaking systematic reviews in 
the proposed research field and discussed with members 
of the research team. The original search strategy devel-
oped for the Embase database has been adapted for each 
included database (see below) and comprises a combi-
nation of text words and the following medical subject 
headings (MeSH) indexing terms: ‘child’, ‘adolescent’, 
‘active immunization’, ‘immunization’, ‘immunization 
programs’, ‘mass immunization’, ‘revaccination’, ‘vacci-
nation’, ‘diptheria vaccine’, ‘diptheria tetanus vaccine’, 
‘diptheria pertussis tetanus’, ‘haemphilus influenzae 
type b vaccine’, ‘hepatitis b vaccine’, ‘meningcoccus 
vaccine’, ‘rubella vaccine’, ‘wart virus vaccine’, ‘papillo-
mavirus vaccines’, ‘decision making’, ‘informed consent’, 
‘parental consent’, ‘treatment refusal’ (box 1). Study 
design filters or restrictions by setting will not be applied 
as the study aims to be inclusive in relation to study design 
and settings eligible for inclusion.
databases
To ensure all the relevant literature is captured, we will 
search the following 10 databases from inception to 
January 2018 and reupdated ahead of study completion 
to inform the wider research study as it progresses: Child 
Development & Adolescent Studies via EBSCOhost, 
Cochrane Central Register of Controlled Trials via The 
Cochrane Library, Cochrane Reviews via The Cochrane 
Library, Cumulative Index to Nursing and Allied Health 
Literature via EBSCOhost, Embase via Ovid, Health Tech-
nology Assessment Database, Medline via Ovid, PsycINFO 
via Ovid, Social Care Online via Social Care Institute for 
Excellence and Web of Science Core Collection: Social 
Sciences Citation Index and Conference Proceedings 
Citation Index-Science. All abstracts will be saved using 
Endnote X8.
Inclusion and exclusion criteria
Quantitative studies will be eligible if vaccine uptake 
following implementation of self-consent procedures 
is reported for young people aged between 10 and 
18 years.11 Qualitative studies reporting the views and 
experiences of key stakeholders in relation adolescent 
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self-consent procedures will also be included. Studies 
related to consent procedures solely targeting parents 
of adolescents or early childhood and adult vaccination 
programmes will not be eligible for inclusion. Relevant 
stakeholders will vary with context but are likely to include 
young people, parents or primary caregivers, healthcare 
professionals, policy makers, community leaders and 
teachers.
We will include a range of study designs. To determine 
whether self-consent procedures can increase uptake 
of vaccination programmes, primary studies reporting 
parallel group randomised controlled trials, quasi-ran-
domised trials, non-randomised controlled trials, 
controlled before and after studies, historically controlled 
studies and retrospective or prospective cohort studies 
that include a control group will be eligible. Qualitative 
studies which use interviews, focus groups, observations 
or open-ended questions allowing free-text responses 
in questionnaires will be included to explore views and 
behaviours related to young people’s self-consent for 
vaccination.
Conference abstracts, reviews, editorials, opinion 
pieces, dissertations, letters and books will only be 
included if they present original data. There will be no 
language or country of origin restriction imposed and 
any relevant full text paper that is not written in English 
will be translated.
study selection
Two reviewers will independently assess the titles and 
abstracts against the predefined eligibility criteria. Full-
text publications of all potentially relevant articles will be 
retrieved and examined for relevance. Any disagreements 
arising will be resolved by discussion. The reference lists 
and bibliographies from relevant studies and systematic 
reviews will be hand-searched for additional primary 
studies not retrieved by the electronic search.
We will use the reference management software 
EndNote X8 to remove duplicates and sort exclusions 
and inclusions. The search strategy and study selec-
tion process will be documented using a PRISMA flow 
diagram.12
data extraction
At least two reviewers will independently extract data 
from selected studies using structured and standardised 
data extraction forms used in our previous qualitative 
and quantitative systematic reviews. In instances where 
multiple publications relate to the same study, these 
will be reported together. The following domains will 
be retrieved: study characteristics (authors, publication 
year, country, aim, study time period, study design, loca-
tion, type of setting, data collection period, data collec-
tion method, sampling strategy, analysis), participant 
characteristics (participant age, sample size, vaccination 
status of participants, socioeconomic indicators, race/
ethnicity, gender and religion) and study results (uptake 
of vaccine, psychological outcomes, healthcare service 
use, incidence of vaccine preventable disease, views and 
behaviours related to self-consent procedures, authors’ 
reported conflicts of interest and study funding sources). 
We will also record data relating to the possible harms 
resulting from self-consent procedures (eg, conflict 
with parents, healthcare professional anxiety). Where 
possible, authors will be contacted for missing or incom-
plete data. Disagreements will be resolved through 
discussion.
box 1 Embase search strategy
1. child/
2. adolescent/
3. (‘Young people#’ OR ‘young person#’ OR ‘young offender#’ OR ad-
olescent# OR adolescence OR youth# OR minor# OR teen OR teens 
OR teenage OR teenaged OR teenager# OR juvenile# OR pupil# OR 
boy# OR girl# OR underage# OR daughter# or son# (school AND 
dropout#) OR (school AND ‘drop out#‘) OR ‘school aged’).mp.
4. active immunization/
5. immunization/
6. immunization programs/
7. mass immunization/
8. revaccination/
9. vaccination/
10. diphtheria vaccine/
11. diphtheria tetanus vaccine/
12. diphtheria pertussis tetanus Haemophilus influenzae type b 
vaccine/
13. hepatitis B vaccine/
14. meningococcus vaccine/
15. rubella vaccine/
16. wart virus vaccine/
17. Papillomavirus Vaccines/
18. (cervical cancer or diptheria or diphtheria or diphteria or DtaP or 
DTP or Hep B or hepatitis or HPV or measles or MenC or MenACWY 
or meningitis or Meningococcal or Neisseria meningitidis or pap-
illomavirus or pertus* or rubella or rubeola or td?ipv or tetanus or 
wart virus or whoop*).tw.
19. (policy OR programme*)
20. (immuniz* OR immunis* OR immunother* OR inoculat* OR innocu-
lat* OR prophyla* OR revaccinat* OR vaccin*).mp.
21. Decision making/
22. Informed consent/
23. Parental consent/
24. Treatment refusal/
25. (assent* OR competen* OR decision-making OR decision making 
OR Gillick OR Fraser OR inform* consent OR mental capacity OR 
minor consent OR parent* consent OR permission* OR presume* 
consent OR treatment refusal OR self consent OR self-consent OR 
opt-out OR opt-in).mp.
26. 1 or 2 or 3
27. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 
or 17
28. 18 and 20
29. 19 and 20
30. 27 or 28 or 29
31. 21 or 22 or 23 or 24 or 25
32. 26 and 30 or 31
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risk of bias and quality assessment
For eligible primary studies, quality assessment will be 
undertaken to illustrate potential sources of bias. As we 
anticipate the majority of eligible studies will be observa-
tional, studies will not automatically be excluded on the 
basis of ‘low’ quality assessment if they are considered 
to contribute relevant information. We propose using: 
the Cochrane Collaboration’s handbook for the assess-
ment of risks of bias for systematic review of randomised 
controlled studies and quasi-randomised intervention 
studies;13 Risk Of Bias in Non-Randomised Studies of 
Interventions (ROBINS-I);14 the NIH Quality Assess-
ment Tool for Observational Cohort and Cross-Sectional 
Studies15 and the Critical Appraisal Skills Programme 
criteria adapted for qualitative studies for evaluating qual-
itative research.16 Quality assessment of primary studies 
will be undertaken independently by two reviewers and 
recorded in an excel spreadsheet. An overall assessment 
of ‘high’, ‘medium’, ‘low’ or ‘unclear’ will be assigned 
and reported.
data synthesis: quantitative studies
We anticipate that the primary quantitative studies will 
be reported narratively as preliminary searches specifi-
cally related to HPV vaccination programmes indicated a 
lack of published studies and the likelihood of heteroge-
neity in relation to study design and reported outcomes. 
However, if sufficiently similar studies are captured, we 
will consider combining individual study results through 
meta-analyses. To assess the heterogeneity between 
studies, we will use the Q-statistic and the I2-statistics.17 
Evidence of heterogeneity will be classified as weak, 
moderate and strong for corresponding I2 of 25%, 
50% and 75%, respectively. If heterogeneity between 
studies is classified as weak, analyses will comprise 
adjusted ORs where available, with unadjusted ORs used 
if not reported. Analyses will be undertaken using the 
meta-analysis function18 available in Stata V.15. We do 
not anticipate sufficient data being available to under-
take subgroup analyses. However, if sufficient data were 
reported, we propose two subgroup analyses to compare 
impact of self-consent procedures by: (1) setting (health-
care vs school) and (2) age of participants (less than 14 
years old vs 14 years and greater).
data synthesis: qualitative studies
The socioecological model19 considers that behaviour is 
shaped by a complex interaction between factors oper-
ating at public policy, community, organisational, inter-
personal and intrapersonal levels. In a previous qualitative 
synthesis, we have shown that young women’s access to 
the HPV vaccine is shaped by decisions at different levels 
of the socioecological model.5 During the analysis, we will 
use the socioecological model to provide a framework 
for understanding how barriers and facilitators operating 
at different levels of the model can provide access to, or 
prevent, young people self-consenting in the context of 
vaccination programmes.
To analyse the qualitative data, the methodology for 
thematic synthesis reported by Thomas and Harden,20 
assisted by the Framework method of qualitative data 
management,21 will be used. These methods are suited 
to studies with a priori aims and objectives. The overall 
purpose of the synthesis will be to ‘pool’ the results 
from individual primary studies by initially separating 
the findings, coding and interpreting the text and then 
combining them through the identification of key themes 
across the studies as well as similarities and differences 
within those themes.22 Thematic synthesis will be led by 
one reviewer reporting to the wider team about interpre-
tation of the data as analysis progresses.
Familiarisation with the dataset will begin with reading 
the full papers. Pertinent sections of the text reported in 
each primary study will represent the basic units for anal-
ysis. Primary charts of the text will be constructed around 
key issues using the Framework Matrix within QSR 
NVivo11 software. For example, initial charts are likely to 
focus on ‘barriers’ and ‘facilitators’ to adolescent self-con-
sent. The primary charts will be retained and revisited as 
required. Streamlined versions will be produced as the 
process of coding, summarising and synthesising the data 
progresses. In subsequent charts, key terms and phrases 
will be retained while repetition within studies and extra-
neous text are removed. During this process, overarching 
themes will be identified and differences or similarities 
explored within these emerging themes.
data synthesis: interrogation
The final stage of the analysis will aim, first, to test 
whether the recommendations developed from the qual-
itative studies have been addressed in evaluative studies 
retrieved for the review and, second, to examine whether 
interventions that match the recommendations result in 
higher uptake in vaccination.9
Patient and public involvement
The Bristol Young People’s Advisory Group comprises 
young people aged 10–17 years who are interested in 
healthcare and research. They meet regularly to help 
researchers with their projects and have been consulted 
about the design of the wider study and participant mate-
rials. They will also be invited to an event at the end of the 
study to consider findings and recommendations with the 
young people, parents, immunisation nurses and school 
staff involved in the study.
EthICs And dIssEMInAtIOn
We will not seek ethical approval for this study because 
the secondary data to be collected cannot be linked to 
individuals. As far as we are aware, this will be the first 
systematic review to collate evidence in relation to adoles-
cent self-consent procedures for vaccination programmes. 
The review comprises part of a larger study. The findings 
of this review will inform the larger study evaluating the 
practicality, acceptability and impact of new self-consent 
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procedures for the schools-based HPV vaccination 
programme in the UK. Findings will also be used to make 
recommendations to improve self-consent procedures for 
young people in vaccination programmes. We anticipate 
the results of this study; this may be of interest to national 
and international stakeholders interested in improving 
uptake in adolescent vaccination programmes.
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